Fusen Pharmaceutical Company Limited
HKEX:1652.HK
1 (HKD) • At close September 11, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -29.448 | -30.993 | 23.791 | 78.405 | 63.814 | 123.814 | 116.336 | 114.768 | 57.268 |
| Depreciation & Amortization
| 35.798 | 34.161 | 23.785 | 22.457 | 21.232 | 16.809 | 16.196 | 15.245 | 15.063 |
| Deferred Income Tax
| 0 | 0 | 0 | -14.547 | -26.252 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 1.453 | 1.153 | 0 | 17.632 | 4.421 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -140.212 | 38.407 | -30.591 | 44.243 | -47.663 | -68.935 | 12.263 | 57.322 | -23.86 |
| Accounts Receivables
| 49.862 | -90.564 | 25.973 | -12.314 | -48.643 | 10.093 | -9.252 | 11.225 | -26.88 |
| Inventory
| -51.069 | 11.196 | -16.43 | -17.011 | 52.383 | -40.281 | 0.273 | 5.854 | -4.672 |
| Accounts Payables
| 0 | 90.564 | -25.973 | 12.314 | 48.643 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -79.282 | 27.211 | -14.161 | 61.254 | -100.046 | -28.654 | 11.99 | 51.468 | -19.188 |
| Other Non Cash Items
| 7.751 | 67.762 | 30.781 | 5.017 | 4.838 | -8.87 | -11.589 | -14.99 | 21.333 |
| Operating Cash Flow
| -73.334 | 110.49 | 47.766 | 153.207 | 20.39 | 62.818 | 133.206 | 172.345 | 69.804 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -88.511 | -23.862 | -110.133 | -58.645 | -200.27 | -104.353 | -9.078 | -19.977 | -27.837 |
| Acquisitions Net
| 0 | 0 | -153 | 0 | -62.978 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -11.325 | 0 | -0.654 | -76.456 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0.715 | 13.538 | 63.933 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -16.955 | 10.016 | -32.728 | 2.971 | 1.996 | 13.63 | 464.592 | 347.643 | 95.022 |
| Investing Cash Flow
| -108.318 | -13.131 | -282.977 | -68.197 | -261.252 | -90.723 | 455.514 | 327.666 | 67.185 |
| Financing Activities: | |||||||||
| Debt Repayment
| -119.73 | -306.527 | -245.569 | -220 | -100 | -396.561 | -693.019 | -729.29 | -1,500.409 |
| Common Stock Issued
| 0 | 0 | 0 | 201.938 | 0 | 335.016 | 0 | 0 | 0 |
| Common Stock Repurchased
| -15.988 | -10.073 | -7.39 | -94.793 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | -6.959 | -8.306 | -3.145 | -5.313 | -1.061 | -25.017 | -157.276 | -14.152 |
| Other Financing Activities
| -12.583 | 271.793 | 281.792 | -0.33 | 110.759 | 163.454 | 359.666 | 598.376 | 1,382.936 |
| Financing Cash Flow
| 88.503 | -51.766 | 20.527 | -116.33 | 5.446 | 100.848 | -358.37 | -288.19 | -131.625 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| -0.108 | 1.45 | -1.291 | -2.686 | 5.352 | 13.544 | -0.119 | 0 | 0 |
| Net Change In Cash
| -93.257 | 47.043 | -215.975 | -34.006 | -230.064 | 86.487 | 230.231 | 211.821 | 5.364 |
| Cash At End Of Period
| 34.849 | 128.106 | 81.063 | 297.038 | 331.044 | 561.108 | 474.621 | 244.39 | 32.569 |